NovaBay Pharmaceuticals, Inc. Share Based Compensation of Revenue

Share Based Compensation of Revenue of NBY for past 10 years: annual, quarterly and twelve month trailing (TTM) including Share Based Compensation of Revenue growth rates and interactive chart.


Highlights and Quick Summary

  • Share Based Compensation of Revenue for the quarter ending June 30, 2022 was 5.06% (a -27.71% decrease compared to previous quarter)
  • Year-over-year quarterly Share Based Compensation of Revenue decreased by -58.42%
  • Annual Share Based Compensation of Revenue for 2021 was 11.08% (a 129.88% increase from previous year)
  • Annual Share Based Compensation of Revenue for 2020 was 4.82% (a -14.23% decrease from previous year)
  • Annual Share Based Compensation of Revenue for 2019 was 5.62% (a 18.32% increase from previous year)
  • Twelve month Share Based Compensation of Revenue ending June 30, 2022 was 7.8% (a -22.77% decrease compared to previous quarter)
  • Twelve month trailing Share Based Compensation of Revenue decreased by -31.7% year-over-year
Trailing Share Based Compensation of Revenue for the last four month:
30 Jun '22 31 Mar '22 31 Dec '21 30 Sep '21
7.8% 10.1% 11.08% 11.42%
Visit stockrow.com/NBY for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Share Based Compensation of Revenue of NovaBay Pharmaceuticals, Inc.

Most recent Share Based Compensation of Revenueof NBY including historical data for past 10 years.

Interactive Chart of Share Based Compensation of Revenue of NovaBay Pharmaceuticals, Inc.

NovaBay Pharmaceuticals, Inc. Share Based Compensation of Revenue for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 5.06% 7.0%
2021 8.71% 12.17% 13.88% 10.13% 11.08%
2020 9.16% 7.33% 2.26% 3.01% 4.82%
2019 0.82% 8.73% 5.14% 8.32% 5.62%
2018 4.5% 5.35% 5.51% 3.7% 4.75%
2017 -5.49% 17.01% 12.03% 32.23% 11.18%
2016 14.28% 18.96% 10.14% 14.37% 14.72%
2015 22.81% 18.42% 49.9% 52.97% 31.55%
2014 54.38% 165.13% 200.81% 96.18% 98.86%
2013 42.16% 20.29% 56.72% 25.98% 34.05%
2012 31.69% 9.39% 45.24% 37.05% 22.71%
2011 26.59% 8.51% 11.08%

Business Profile of NovaBay Pharmaceuticals, Inc.

Sector: Healthcare
Industry: Biotechnology